Mumbai, Aug. 20 -- Glenmark Pharmaceuticals (Glenmark) today announced the receipt of U.S. FDA approval for Fluticasone Propionate Nasal Spray USP, 0.05 mg/spray.

Published by HT Digital Content Services with permission from Capital Market....